Revance Therapeutics | Marketskapitalisme

Market Capitalization Endring Dato
ALKERMES USD 4.63B 36M 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Pacira USD 1.33B 234M 2024-03
Supernus Pharmaceuticals USD 1.89B 307M 2024-03



Revance Therapeutics Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.